Patent details
LUC00144 Product Name: ixekizumab
Basic Information
- Publication number:
- LUC00144
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP141636860
- Legal Status:
- Withdrawn
- Application number:
- LUC00144
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1085
- Marketing Authorization Type:
- Marketing Authorization Date:
- 28/04/2016
- Marketing Authorization Status:
- Claimed
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 10/01/2020
- First Marketing Authorization date:
- 28/04/2016
- Grant date:
- Activation date:
- Publication date:
- 10/01/2020
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 02/06/2029
- SPC Extension Expiration:
- 02/06/2029
- Rejection date:
- Withdrawal date:
- 03/02/2022
Owner
- From:
- 02/11/2020
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
History of Owners
- From:
- 10/01/2020
- To:
- 02/11/2020
- Name:
- Genentech, Inc.
- Address:
- 1 DNA Way, South San Francisco, CA 94080-4990, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 10/01/2020
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2020/03
- Publication date:
- 10/02/2020
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/13
- Publication date:
- 07/12/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
3
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2022/04
- Publication date:
- 04/03/2022
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20200000345A
- Date Registered:
- 02/11/2020
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- NOVARTIS PHARMA AG
- Address:
- Lichtstrasse 35, 4056, Basel, Switzerland (CH)
Removed Pledgee
- Name:
- Address:
Other
- Note:
- Suspension de la procédure de délivrance sur demande du déposant / Grant procedure suspended at the request of the applicant
| Filing date | Document type | Number of pages |
|---|---|---|
| 03/02/2022 | Incoming Correspondence (Post) | 1 |
| 03/02/2022 | Outgoing Correspondence | 1 |
| 10/01/2020 | Application Form | 4 |
| 10/11/2020 | Outgoing Correspondence | 1 |
| 10/01/2020 | General Document | 8 |
| 02/11/2020 | Request For Change | 11 |
| 10/01/2020 | Incoming Correspondence (Post) | 2 |
| 10/01/2020 | General Document | 68 |
| 10/01/2020 | General Document | 3 |
| 10/01/2020 | Publication | 1 |
| 10/01/2020 | Outgoing Correspondence | 1 |